Global Consumer Health Contract Manufacturing Market Size Study, by Product (Over-the-counter Drugs, Nutritional Supplements, Personal Care Products, Medical Devices), by Service, by End-use, and Regional Forecasts 2022-2032

Description

The Global Consumer Health Contract Manufacturing Market was valued at approximately USD 116.65 billion in 2023 and is projected to witness significant expansion at a compound annual growth rate (CAGR) of 8.72% over the forecast period 2024-2032. The increasing demand for outsourcing production capabilities in the consumer health sector is fueled by rising health awareness, expanding pharmaceutical and nutraceutical consumption, and the growing complexity of regulatory requirements. Companies are actively leveraging contract manufacturers to streamline operations, ensure cost efficiencies, and meet the surging consumer demand for over-the-counter (OTC) drugs, nutritional supplements, and personal care products.

The market's growth is further propelled by the expansion of wellness trends, the increasing preference for preventive healthcare, and the surge in demand for dietary supplements enriched with vitamins, probiotics, and herbal extracts. Additionally, contract manufacturing organizations (CMOs) are integrating advanced manufacturing technologies, including automation and AI-driven production analytics, to optimize efficiency and enhance product quality. However, challenges such as supply chain disruptions, stringent regulatory compliance, and pricing pressures due to increasing raw material costs may impede market growth. Nevertheless, the rise in demand for personalized healthcare products and sustainable production methodologies is expected to unlock new growth opportunities.

Regionally, North America dominates the market, driven by an established pharmaceutical and consumer health industry, strong regulatory frameworks, and the presence of major contract manufacturers. Europe follows closely, supported by stringent quality control norms and a highly competitive healthcare ecosystem. Meanwhile, the Asia Pacific region is projected to be the fastest-growing market due to rising disposable incomes, increasing healthcare expenditures, and growing investments in pharmaceutical contract manufacturing. Emerging economies such as China and India are particularly contributing to this growth through expansions in production capabilities and favorable government policies. Latin America and the Middle East & Africa are also witnessing steady growth, backed by expanding healthcare awareness and increasing local manufacturing investments.

The competitive landscape of the Consumer Health Contract Manufacturing Market is characterized by extensive R&D investments, strategic mergers and acquisitions, and collaborations between pharmaceutical giants and CMOs. Key players are prioritizing technological advancements in formulation and packaging while expanding their global footprints to cater to a broader customer base. With sustainability and efficiency emerging as critical industry trends, the market is poised for continued expansion, offering lucrative opportunities for both established and emerging players.

Major market players included in this report are:

Catalent, Inc.
Lonza Group AG
Recipharm AB
Piramal Pharma Solutions
Siegfried Holding AG
Jubilant Life Sciences Ltd.
Famar S.A.
CordenPharma International
Aenova Group
Eurofins Scientific SE
Capsugel (Part of Lonza)
Almac Group
Thermo Fisher Scientific, Inc.
Patheon Inc.
Fareva Group

The detailed segments and sub-segments of the market are explained below:

By Product:

Over-the-counter Drugs
Nutritional Supplements
Personal Care Products
Medical Devices

By Service:

Manufacturing
Packaging
Research & Development

By End-use:

Pharmaceutical Companies
Biotechnology Firms
Nutraceutical Companies

By Region:

North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
Rest of Europe
Asia Pacific
China
India
Japan
Australia
South Korea
Rest of Asia Pacific
Latin America
Brazil
Mexico
Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Years considered for the study are as follows:

Historical Year: 2022, 2023
Base Year: 2023
Forecast Period: 2024-2032

Key Takeaways:

Market estimates & forecasts for 10 years from 2022 to 2032.
Annualized revenues and regional-level analysis for each market segment.
Detailed analysis of the geographical landscape with country-level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approaches.
Analysis of the competitive structure of the market.
Demand-side and supply-side analysis of the market.

Chapter 1. Global Consumer Health Contract Manufacturing Market Executive Summary

1.1. Global Consumer Health Contract Manufacturing Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
- 1.3.1. By Product
  - Over-the-counter Drugs
  - Nutritional Supplements
  - Personal Care Products
  - Medical Devices
- 1.3.2. By Service
  - Manufacturing
  - Packaging
  - Research & Development
- 1.3.3. By End-use
  - Pharmaceutical Companies
  - Biotechnology Firms
  - Nutraceutical Companies
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Consumer Health Contract Manufacturing Market Definition and Research Assumptions

2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
- 2.3.1. Inclusion & Exclusion
- 2.3.2. Limitations
- 2.3.3. Supply Side Analysis
  - Availability
  - Infrastructure
  - Regulatory Environment
  - Market Competition
  - Economic Viability (Consumer's Perspective)
- 2.3.4. Demand Side Analysis
  - Regulatory Frameworks
  - Technological Advancements
  - Environmental Considerations
  - Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates

Chapter 3. Global Consumer Health Contract Manufacturing Market Dynamics

3.1. Market Drivers
- 3.1.1. Rising Health Awareness
- 3.1.2. Expanding Pharmaceutical and Nutraceutical Consumption
- 3.1.3. Growing Complexity of Regulatory Requirements
- 3.1.4. Increasing Preference for Preventive Healthcare & Wellness Trends
- 3.1.5. Technological Advancements in Automation & AI-driven Production
3.2. Market Challenges
- 3.2.1. Supply Chain Disruptions
- 3.2.2. Stringent Regulatory Compliance
- 3.2.3. Pricing Pressures due to Increasing Raw Material Costs
3.3. Market Opportunities
- 3.3.1. Demand for Personalized Healthcare Products
- 3.3.2. Adoption of Sustainable Production Methodologies
- 3.3.3. Integration of Advanced Manufacturing Technologies

Chapter 4. Global Consumer Health Contract Manufacturing Market Industry Analysis

4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.1.6. Futuristic Approach to Porter's 5 Force Model
- 4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
- 4.2.1. Political
- 4.2.2. Economical
- 4.2.3. Social
- 4.2.4. Technological
- 4.2.5. Environmental
- 4.2.6. Legal
4.3. Top Investment Opportunity
4.4. Top Winning Strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Consumer Health Contract Manufacturing Market Size & Forecasts by Product 2022-2032

5.1. Segment Dashboard
5.2. Revenue Trend Analysis by Product
- 5.2.1. Over-the-counter Drugs
- 5.2.2. Nutritional Supplements
- 5.2.3. Personal Care Products
- 5.2.4. Medical Devices

Chapter 6. Global Consumer Health Contract Manufacturing Market Size & Forecasts by Service 2022-2032

6.1. Segment Dashboard
6.2. Revenue Trend Analysis by Service
- 6.2.1. Manufacturing
- 6.2.2. Packaging
- 6.2.3. Research & Development

Chapter 7. Global Consumer Health Contract Manufacturing Market Size & Forecasts by End-use 2022-2032

7.1. Segment Dashboard
7.2. Revenue Trend Analysis by End-use
- 7.2.1. Pharmaceutical Companies
- 7.2.2. Biotechnology Firms
- 7.2.3. Nutraceutical Companies

Chapter 8. Global Consumer Health Contract Manufacturing Market Size & Forecasts by Region 2022-2032

8.1. North America Market
- 8.1.1. U.S. Market
  - 8.1.1.1. Product Breakdown Size & Forecasts, 2022-2032
  - 8.1.1.2. Service Breakdown Size & Forecasts, 2022-2032
  - 8.1.1.3. End-use Breakdown Size & Forecasts, 2022-2032
- 8.1.2. Canada Market
8.2. Europe Market
- 8.2.1. U.K. Market
- 8.2.2. Germany Market
- 8.2.3. France Market
- 8.2.4. Spain Market
- 8.2.5. Italy Market
- 8.2.6. Rest of Europe Market
8.3. Asia Pacific Market
- 8.3.1. China Market
- 8.3.2. India Market
- 8.3.3. Japan Market
- 8.3.4. Australia Market
- 8.3.5. South Korea Market
- 8.3.6. Rest of Asia Pacific Market
8.4. Latin America Market
- 8.4.1. Brazil Market
- 8.4.2. Mexico Market
- 8.4.3. Rest of Latin America Market
8.5. Middle East & Africa Market
- 8.5.1. Saudi Arabia Market
- 8.5.2. South Africa Market
- 8.5.3. Rest of Middle East & Africa Market

Chapter 9. Competitive Intelligence

9.1. Key Company SWOT Analysis
- 9.1.1. Catalent, Inc.
- 9.1.2. Lonza Group AG
- 9.1.3. Recipharm AB
9.2. Top Market Strategies
9.3. Company Profiles
- 9.3.1. Catalent, Inc.
  - 9.3.1.1. Key Information
  - 9.3.1.2. Overview
  - 9.3.1.3. Financial (Subject to Data Availability)
  - 9.3.1.4. Product Summary
  - 9.3.1.5. Market Strategies
- 9.3.2. Piramal Pharma Solutions
- 9.3.3. Siegfried Holding AG
- 9.3.4. Jubilant Life Sciences Ltd.
- 9.3.5. Famar S.A.
- 9.3.6. CordenPharma International
- 9.3.7. Aenova Group
- 9.3.8. Eurofins Scientific SE
- 9.3.9. Capsugel (Part of Lonza)
- 9.3.10. Almac Group
- 9.3.11. Thermo Fisher Scientific, Inc.
- 9.3.12. Patheon Inc.
- 9.3.13. Fareva Group

Chapter 10. Research Process

10.1. Research Process
- 10.1.1. Data Mining
- 10.1.2. Analysis
- 10.1.3. Market Estimation
- 10.1.4. Validation
- 10.1.5. Publishing
10.2. Research Attributes